Search Within

Lymphoma

Formats
  1. Meeting Abstract (1382)
  2. Journal Article (1050)
  3. Book Section (64)
  4. Review (63)
  5. Editorial (38)
  6. Research Letter (37)
  7. Guidelines (18)
  8. Conference Paper (15)
  9. Correspondence (11)
  10. Miscellaneous (5)
  11. Book Whole (4)
Groups
  1. Center for Hematologic Malignancies (2687)
  2. Department of Medicine (2687)
  3. Hematologic Malignancies, Division of (2687)
  4. Population Sciences Research Program (741)
  5. Survivorship Research (651)
  6. Executive Committee, Center for Hematologic Malignancies (391)

More Groups

People
  1. Andrew Zelenetz (781)
  2. Steven Horwitz (663)
  3. Maria Palomba (440)
  4. Ariela Noy (368)
  5. David Straus (360)
  6. Alison Moskowitz (355)

More People

Years
  1. 2025 (34)
  2. 2024 (141)
  3. 2023 (180)
  4. 2022 (170)
  5. 2021 (171)
  6. 2020 (170)

More Years

Publications
  1. Blood (875)
  2. Journal of Clinical Oncology (275)
  3. Hematological Oncology (110)
  4. Leukemia and Lymphoma (81)
  5. British Journal of Haematology (80)
  6. Haematologica (71)

More Publications

Publishers
  1. American Society of Hematology (940)
  2. American Society of Clinical Oncology (291)
  3. Elsevier Inc. (186)
  4. Wiley Blackwell (174)
  5. John Wiley & Sons (95)
  6. Nature Publishing Group (92)

More Publishers

Results (2687)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • A phase 1 trial of abexinostat with ibrutinib in relapsed/refractory mantle cell lymphoma and non-germinal center diffuse large B cell lymphoma
    Correspondence

    Gurumurthi, A.; Bantilan, K. S.; Hamlin, P. A.; Kumar, A.; Matasar, M.; Zhu, M.; Joseph, A.; Castro, A.; Biggar, E.; Salles, G.; more...
    Leukemia and Lymphoma (2024)

    Fulltext@MSK | Save
  • Valemetostat for patients with relapsed or refractory peripheral T-cell lymphoma (VALENTINE-PTCL01): A multicentre, open-label, single-arm, phase 2 study
    Journal Article

    Zinzani, P. L.; Izutsu, K.; Mehta-Shah, N.; Barta, S. K.; Ishitsuka, K.; Córdoba, R.; Kusumoto, S.; Bachy, E.; Cwynarski, K.; Gritti, G.; more...
    Lancet Oncology (2024)

    Fulltext@MSK | Save
  • Valemetostat monotherapy in patients with relapsed or refractory non-Hodgkin lymphoma: A first-in-human, multicentre, open-label, single-arm, phase 1 study
    Journal Article

    Maruyama, D.; Jacobsen, E.; Porcu, P.; Allen, P.; Ishitsuka, K.; Kusumoto, S.; Narita, T.; Tobinai, K.; Foss, F.; Tsukasaki, K.; more...
    Lancet Oncology (2024)

    Fulltext@MSK | Save
  • Leucine zipper-based immunomagnetic purification of CAR T cells displaying multiple receptors
    Journal Article

    James, S. E.; Chen, S.; Ng, B. D.; Fischman, J. S.; Jahn, L.; Boardman, A. P.; Rajagopalan, A.; Elias, H. K.; Massa, A.; Manuele, D.; more...
    Nature Biomedical Engineering (2024)

    Fulltext@MSK | Save
  • T-cell-based therapies for treating relapsed or refractory mantle cell lymphoma
    Review

    Epstein-Peterson, Z. D.; Palomba, M. L.
    Hematology-American Society of Hematology Education Program (2024)

    Fulltext@MSK | Save
  • Through thick and thin: Confronting the aggressive cutaneous T-cell lymphomas
    Review

    Stuver, R.; Horwitz, S. M.
    Hematology-American Society of Hematology Education Program (2024)

    Fulltext@MSK | Save
  • Differences in ancestry and presence of gastric precursor lesions in individuals with young- and average-onset gastric cancer
    Journal Article

    Magahis, P. T.; Cornet, N.; Tang, L.; Arora, K.; Hingorani, N.; King, S.; Markowitz, A. J.; Schattner, M.; Shimada, S.; Maron, S. B.; more...
    Cancer Medicine (2024)

    Fulltext@MSK | Save
  • A novel JAK2 fusion in T-cell prolymphocytic leukemia
    Meeting Abstract

    Eren, O. C.; Stuver, R.; Zhou, T.; Zaidinski, M.; Moskowitz, A. J.; Horwitz, S. M.; Ewalt, M. D.; Zhang, Y.; Lim, M.
    Virchows Archiv (2024)

    Fulltext@MSK | Save
  • ASTCT and USCLC clinical practice recommendations for allogeneic stem cell transplant in mycosis fungoides and Sézary syndrome
    Guidelines

    Goyal, A.; O'Leary, D.; Dabaja, B.; Weng, W. K.; Zain, J.; Cutler, C.; Guitart, J.; Kim, Y. H.; Geskin, L. J.; Hoppe, R. T.; more...
    Transplantation and Cellular Therapy (2024)

    Fulltext@MSK | Save
  • ERK1/2 pro-survival signalling is suppressed by pirtobrutinib in ibrutinib-resistant MYD88-mutated lymphoma cells
    Journal Article

    Munshi, M.; Liu, X.; Kofides, A.; Tsakmaklis, N.; Hunter, Z. R.; Guerrera, M. L.; Canning, A.; Gustine, J. N.; Liu, S.; Hatcher, J. M.; more...
    British Journal of Haematology (2024)

    Fulltext@MSK | Save